Attached files
| file | filename |
|---|---|
| EX-10.7 - EXHIBIT 10.7 - OPIANT PHARMACEUTICALS, INC. | v476254_ex10-7.htm |
| EX-32.2 - EXHIBIT 32.2 - OPIANT PHARMACEUTICALS, INC. | v476254_ex32-2.htm |
| EX-31.2 - EXHIBIT 31.2 - OPIANT PHARMACEUTICALS, INC. | v476254_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - OPIANT PHARMACEUTICALS, INC. | v476254_ex31-1.htm |
| EX-21.1 - EXHIBIT 21.1 - OPIANT PHARMACEUTICALS, INC. | v476254_ex21-1.htm |
| EX-10.52 - EXHIBIT 10.52 - OPIANT PHARMACEUTICALS, INC. | v476254_ex10-52.htm |
| EX-10.9 - EXHIBIT 10.9 - OPIANT PHARMACEUTICALS, INC. | v476254_ex10-9.htm |
| EX-10.6 - EXHIBIT 10.6 - OPIANT PHARMACEUTICALS, INC. | v476254_ex10-6.htm |
| EX-10.5 - EXHIBIT 10.5 - OPIANT PHARMACEUTICALS, INC. | v476254_ex10-5.htm |
| 10-K - 10-K - OPIANT PHARMACEUTICALS, INC. | v476254_10k.htm |
EXHIBIT 32.1
CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of Opiant Pharmaceuticals, Inc. (the “Company") for the year ended July 31, 2017, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I Dr. Roger Crystal, Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: October 13, 2017
| By: | /s/ Dr. Roger Crystal | ||
| Dr. Roger Crystal | |||
| Chief Executive Officer | |||